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West Nile virus (WNV) causes an acute neurological
infection attended by massive neuronal cell death.
However, the mechanism(s) behind the virus-
induced cell death is poorly understood. Using a li-
brary containing 77,406 sgRNAs targeting 20,121
genes, we performed a genome-wide screen fol-
lowed by a second screen with a sub-library. Among
the genes identified, seven genes, EMC2, EMC3,
SEL1L, DERL2, UBE2G2, UBE2J1, and HRD1, stood
out as having the strongest phenotype, whose
knockout conferred strong protection against WNV-
induced cell death with two different WNV strains
and in three cell lines. Interestingly, knockout of
these genes did not block WNV replication. Thus,
these appear to be essential genes that link WNV
replication to downstream cell death pathway(s). In
addition, the fact that all of these genes belong to
the ER-associated protein degradation (ERAD)
pathway suggests that this might be the primary
driver of WNV-induced cell death.INTRODUCTION
West Nile virus (WNV) infection has emerged as a serious
global health problem, and massive neuronal cell death
induced by WNV is one of the major causes of mortality and
morbidity. It has been shown that apoptosis occurs after
WNV infection, and inhibition of apoptosis can reduce neuronal
cell death (Kleinschmidt et al., 2007; Parquet et al., 2001;
Samuel et al., 2007; Shrestha et al., 2003). It has also been
shown that WNV-induced cell death can occur by either
apoptosis or necrosis, depending on the dosage of infection
(Chu and Ng, 2003). Whereas the exact mechanism of how
WNV triggers these downstream cell death pathways is not
clear, it likely involves host factors, because WNV itself en-
codes only ten proteins (Brinton, 2014). A common approachto identifying viral host factors is genome-wide functional
screening in cultured cells.
Currently, such screens, including several to identify host
factors for WNV and other flaviviruses (Gilfoy et al., 2009;
Krishnan et al., 2008; Li et al., 2009; Sessions et al., 2009; Ya-
sunaga et al., 2014), are mostly performed using RNAi. How-
ever, this approach has several pitfalls: (1) gene silencing is
generally not complete; (2) silencing efficiency between
different siRNAs or shRNAs targeting the same gene can vary
dramatically; and (3) off-target effects can perturb unintended
targets. Thus, it is not surprising that the results from different
RNAi screens may not be concordant. For example, the overlap
was poor between three independent genome-wide functional
screens using siRNA performed to identify host genes linked
to HIV replication (Brass et al., 2008; Ko¨nig et al., 2008; Zhou
et al., 2008). Although hundreds of genes were identified in
each screen, only three genes were identified in all three
screens, and these did not include the obvious positive genes
CD4 and CXCR4 (R4-tropic HIV challenge; Bushman et al.,
2009). This lack of concordance suggests that further improve-
ment in genome-wide functional screening of cultured cells is
needed.
The CRISPR-Cas9 system has recently been developed as a
tool for gene editing in mammalian cells (Chang et al., 2013;
Cho et al., 2013; Cong et al., 2013; Jinek et al., 2013). This sys-
tem allows easy knockout of both alleles in a substantial percent-
age of treated cells (Chang et al., 2013; Cho et al., 2013; Cong
et al., 2013; DiCarlo et al., 2013; Gasiunas et al., 2012; Hwang
et al., 2013; Jiang et al., 2013; Jinek et al., 2012, 2013; Mali
et al., 2013; Qi et al., 2013). Compared with RNAi-mediated
gene silencing, the gene-silencing efficiency of each single-
guide RNA (sgRNA) is uniform—in most cases, the target gene
is completely eliminated. Thus, the CRISPR system has potential
as an improved approach for performing genome-wide
screening, as suggested by recent reports (Gilbert et al., 2014;
Koike-Yusa et al., 2014; Konermann et al., 2015; Sanjana et al.,
2014; Shalem et al., 2014; Wang et al., 2014; Zhou et al.,
2014). Here, we have independently developed a method based
on this system and identified cellular factors that appear to be
essential factors that link WNV replication to downstream cell
death pathway(s).Cell Reports 12, 673–683, July 28, 2015 ª2015 The Authors 673
Figure 1. Schematic of Functional Screening for Genes that Are
Essential for West-Nile-Virus-Induced Cell Killing
For the first and second round of screen, the sgRNA library sequences can
be found in Data Sets S1 and S3 and the sgRNAs identified in surviving
cells can be found in Data Sets S2 and S4 (GEO: GSE69666), respectively;
674 Cell Reports 12, 673–683, July 28, 2015 ª2015 The AuthorsRESULTS
The Strategy for Identifying Genes Essential
for WNV-Induced Cell Death
We designed a screening strategy to identify genes essential for
WNV-induced killing, as illustrated in Figure 1. The exact proce-
dure used is as follows. (1) A sgRNA library was synthesized as
an oligo pool, with 77,406 unique sgRNAs covering 20,121 genes
in the human genome (Data Set S1). To ensure complete gene
disruption, the target sites were chosen in a region close to the
translation initiation site, and most genes were covered four
times. It is noteworthy that the sgRNAs start with either A or G,
because our previous study showed that the preferred transcrip-
tion initiation nucleotide for the U6 promoter can be either A or G
(Ma et al., 2014). (2) The sgRNA oligo pool was PCR amplified
and cloned into the lentiviral vector, pLB. To test its quality, we
PCR amplified the library and analyzed the amplicons with
deep sequencing. The results showed that at least 90% of the
sgRNAs were retained in the plasmid library (Data Set S1). The
library vector pool was then packaged with VSV-G pseudotyping
to generate the lentiviral library. (3) The lentiviral sgRNA library
was transduced into 293FT cells. To minimize the chance of in-
serting multiple sgRNAs into the same cell, we employed a low
multiplicity of infection (moi) to obtain a transduction rate of
around 5%. To enrich for sgRNA-harboring cells, the transduced
cells were sorted using an EGFP marker expressed by the lenti-
viral vector. (4) Cells harboring the sgRNA library were trans-
fected with a plasmid that transiently expresses Cas9 to disrupt
the particular gene targeted by the stably expressed sgRNA. The
control groups were transfected with a plasmid that did not ex-
press Cas9. (5) The transfected cells were infected with WNV
strain B956 and incubated for 12 days to select for cells resistant
to virus-induced killing. Numerous colonies could be seen in
Cas9-transfected cells, whereas there were very few colonies
in the control group, suggesting that resistance was mostly
due to Cas9-mediated gene disruption. (6) The sgRNAs in the
surviving cells were PCR amplified and deep sequenced using
Illumina second-generation sequencing to identify the genes
that had been targeted. The experiments were repeated three
times independently.
Different sizes of colonies, from big colonies with hundreds of
cells to small colonies with only a few cells, were observed. Big
colonies were likely derived from cells harboring sgRNAs
whose target genes are essential for WNV-induced cell death
but do not affect cell growth and therefore expand rapidly. As
a consequence, the sgRNAs in these colonies should have a
high number of reads. By contrast, small colonies were prob-
ably derived from cells harboring sgRNAs whose target genes
are only partially required for WNV-induced cell death or are
partially required for cell survival or growth, and the sgRNAs
in these small colonies should have only a few reads. It is
also possible that low knockout efficiency for an sgRNA, even
one targeting a gene whose knockout confers strong resistance
to WNV-induced killing, might limit the number of reads (thegenes identified can be found in Data Sets S2, S4, and S5; and the
genes with highest sgRNA reads are summarized in Tables S1 and S3,
respectively.
Table 1. The Top Genes in Second-Round Screening
Gene Name
sgRNAs
Total sgRNAsExp No. 1 Exp No. 2 Exp No. 3
SEL1L 7 6 7 20
UBE2J1 6 6 6 18
EMC3 4 6 4 14
EMC2 4 4 3 11
DERL2 3 5 3 11
UBE2G2 2 3 3 8
Only sgRNAs with more than 2,000 reads were counted, and only genes
with eight or more sgRNAs identified are shown. The raw sgRNA reads
data can be found in Data Set S4, GEO: GSE69666.colonies will be big for these types of sgRNAs if the gene was
knocked out in the founder cell, but because of the low
knockout efficiency of the sgRNA, the number of colonies will
be fewer). Other reasons, such as off-target effects, could
also cause variability in colony size and sgRNA reads. Howev-
er, in general, a high number of sgRNA reads indicates that
these sgRNAs target genes whose knockout confers strong
resistance to WNV-induced cell death but does not affect cell
growth.
In total, 28,429 sgRNAswith reads numberingmore than ten in
three independent experiments were identified (Data Set S2;
GEO: GSE69666). Multiple sgRNAs with a high number of reads
were seen for three genes, EMC2, EMC3, and SEL1L, in each of
three independent experiments (Table S1). For example, one
SEL1L sgRNA (sgRNA21067) had the highest number of total
reads and another two (sgRNA45498 and sgRNA30740) also
had high numbers of reads (1,437 and 852, respectively),
whereas two EMC3 sgRNAs (sgRNA59423 and sgRNA11892)
ranked number 3 and 5, respectively, and two EMC2 sgRNAs
(sgRNA70193 and sgRNA59282) ranked number 10 and 29,
respectively (Data Set S2; Table S1). Thus, these three genes
might be truly essential to WNV-induced cell death. Similar mul-
tiple sgRNAs with high numbers of reads were not seen for most
other genes, suggesting that some of these results represent
‘‘noise.’’ To test this hypothesis, we randomly chose five genes
with different numbers of sgRNAs identified in three independent
experiments, and two sgRNAs were designed for each gene (Ta-
ble S2). EMC2 was included as a positive control. The sgRNA-
and Cas9-expressing plasmids were co-transfected with a
plasmid expressing a puromycin-resistance gene, and the posi-
tively transfected cells were selected with puromycin. The
genome-editing efficiency of each sgRNA was determined by
amplification of target sites followed by deep sequencing.
Most target sites were efficiently modified (Table S2). Indeed,
only cells treated with EMC2 sgRNAs showed resistance to
WNV-induced killing (Figure S1). In addition, only cells treated
with EMC2 sgRNAs grew to confluence after 6 days of virus chal-
lenge, whereas cells treated with other sgRNAs finally died out
(data not shown), suggesting that only EMC2 is a truly essential
gene and that the other four genes represent noise. Thus, except
for EMC2, EMC3, and SEL1L, which have multiple sgRNAs with
high numbers of reads, most of the sgRNAs identified could be
the result of a high noise level.To improve data quality and distinguish essential WNV-
induced cell death genes from noise, we performed a second
round of screening using a sub-library constructed with sgRNAs
targeting the genes identified in the first round that had more
than five sgRNAs in three independent experiments (Data Set
S2) and also some genes identified in a pilot screen (Data Set
S3). A previous genome-wide screen using a siRNA library iden-
tified 283 host-susceptibility factors that are required for WNV
replication (Krishnan et al., 2008). Because inhibition of WNV
replication might also render the cells resistant to WNV-induced
killing, we also included 50 genes with the highest scores from
that screen (Krishnan et al., 2008). We designed a sub-library
that contains 9,068 sgRNAs targeting 1,166 genes (eight
sgRNAs for each gene; Data Set S3) and performed a second
round of screening in the same way as in Figure 1.
Knockout of the Seven Genes Confers Almost Complete
Protection against WNV-Induced Cell Death
To identify key genes with strong phenotypes that are dispens-
able for cellular survival and yet essential for virus-induced
host cell killing, we counted only sgRNAs with high numbers of
reads (>2,000). Six genes, SEL1L, UBE2J1, EMC3, EMC2,
DERL2, and UBE2G2, stood out with the highest numbers of
sgRNAs in three independent experiments (Table 1; Data Set
S4; GEO: GSE69666) and appear to be truly essential genes,
because multiple sgRNAs exhibiting high numbers of reads for
these genes occurred in three independent experiments (Table
S3; Data Set S4). It appears that, for a particular gene, the
knockout efficiency of different sgRNAs can vary signifi-
cantly—the sgRNAs with high knockout efficiency tend to have
many reads in all three experiments, whereas sgRNAs with low
knockout efficiency tend to have few or no reads in all three ex-
periments (Table S3). For example, only two sgRNAs (out of
eight) for UBE2G2 have a high number of reads in three experi-
ments, whereas the other six sgRNAs have a low number of
reads (Table S3), which is consistent with previous studies
(Koike-Yusa et al., 2014; Shalem et al., 2014; Wang et al.,
2014). Thus, if we looked only at the total number of sgRNAs
that appeared in three independent experiments, we might
miss the truly essential genes. And, if a given sgRNA is enriched
in three independent experiments, it is likely that the gene tar-
geted by this sgRNA is a truly essential gene. According to this
rule, we revisited the data from the first round and found that
one of the sgRNAs targeting the HRD1 (SYVN1) gene had a
high number of reads in all three experiments, although the total
number of sgRNAs identified for this gene was only three. In fact,
this sgRNA had the second highest number of total reads (Data
Set S2), suggesting that it might also be an essential WNV-
induced cell death factor. Thus, we included this gene along
with six other genes identified in the second round for validation.
To validate the above-mentioned seven genes, we derived
cells with each of these genes knocked out using two different
sgRNAs for each gene. The genome-editing efficiency of the
sgRNAs was first determined by deep sequencing of the target
sites. A high allele-modification rate (more than 99% for most
sgRNAs) was observed (Figure 2A), which is consistent with
what was reported earlier (Shalem et al., 2014). We also deter-
mined the knockout efficiency using western blot. The resultsCell Reports 12, 673–683, July 28, 2015 ª2015 The Authors 675
Figure 2. The Genes Whose Knockout Confers Resistance to WNV-
Induced Cell Death
(A) The target site modification rate of the sgRNAs. The genes were mainly
identified in the second round of screening (Data Set S4; GEO: GSE69666).
See also Table S2, showing similar rates of target site modification in another
candidate genes validation experiment. Two sgRNAs were designed for each
gene and inserted into a pX330 vector in which Cas9 is expressed (Cong et al.,
2013). The sgRNA constructs and Cas9-expressing plasmid were co-trans-
fected with a puromycin expression plasmid into 293FT cells, and the cells
were selected with puromycin to eliminate the untransfected cells. The target
site modification rate was determined by amplification of the target sites fol-
lowed by deep sequencing. CBLL1 and HMGCR were two previously identi-
fied WNV host-susceptibility factors.
(B) Western blotting to confirm the knockout efficiency in six of the seven
genes in (A). Actin or HSP90 is included as inner reference.
(C) The cells derived from (A) were challenged with WNV (strain B956) at moi =
2 after puromycin selection. After incubating for 3 days, cell viabilities were
evaluated with the MTT assay. The cell viability was normalized to the
respective controls without WNV treatment. Error bar represents 1 SD (n = 3).
See also Figure S1 for similar results.showed that most protein was eliminated (Figure 2B), which is
consistent with deep-sequencing data for the target sites, indi-
cating that they were mutated in most cells. A small fraction of676 Cell Reports 12, 673–683, July 28, 2015 ª2015 The Authorsthe indels actually caused in-frame mutations (data no shown),
and thus, low levels of the targeted proteins were detected in
most samples (Figure 2B).
These cells were then challenged with WNV. A significant
portion of the cells survived in EMC2 and EMC3 knockout cells,
and most SEL1L, DERL2, UBE2G2, UBE2J1, and HRD1
knockout cells survived, whereas very few control cells survived
after 3 days of incubation (Figure 2C), suggesting that these
genes are essential for WNV-induced cell death. Two previously
identified WNV host-susceptibility factors (HSFs), HMGCR
(Mackenzie et al., 2007) and CBLL1 (Fernandez-Garcia et al.,
2011; Krishnan et al., 2008), which are required for WNV replica-
tion, were included as positive controls but did not confer resis-
tance when targeted (Figure 2C). In addition, cells treated with
sgRNAs targeting the seven genes identified in the present study
kept growing until confluent, whereas all of the cells treated with
sgRNAs targeting HMGCR and CBLL1 died out over time (data
not shown), suggesting that the host genes identified with our
strategy are keyWNV-induced cell death genes with strong phe-
notypes, whose knockout is sufficient to confer resistance to
WNV-induced cell killing. It is not surprising that knockout of pre-
viously identified host factors, such as HMGCR and CBLL1, did
not confer resistance, because the basis for their previous iden-
tification was different: their knockdown led to reduced WNV
replication at certain time points (Krishnan et al., 2008; Macken-
zie et al., 2007).
Genes with Many sgRNAs with Low Numbers of Reads
If sgRNAs with fewer reads are also counted (>50), many genes
would have a substantial number of sgRNAs and, in some cases,
a very high number of sgRNAs would be identified (Data Set S5).
For example, DYNC2LI1 had 20 sgRNAs identified in three ex-
periments, which is only slightly fewer than EMC2 (22 sgRNAs),
SEL1L (22 sgRNAs), or UBE2J1 (21 sgRNAs; Data Set S5). Hav-
ing a high number of sgRNAs identified in three independent
experiments suggests that these genes might also be truly
essential genes required for WNV-induced cell death. However,
the low number of reads suggests that the cells harboring these
sgRNAs did not expand much, even when incubated for 12 days
after WNV challenge. This is actually consistent with what we
observed during screening: whereas big colonies with hundreds
of cells could be observed, small colonies with only a few cells
could also be seen (data not shown). The reason for this limited
expansion might be either that knockout of these genes
conferred only partial resistance or that the genes knocked out
contribute to normal cell growth. These genes are not our main
focus and will not be characterized further in this study. Howev-
er, it is useful to know that these genesmight be involved inWNV
replication and/or in WNV-induced cell death.
Knockout of the Seven Genes Did Not Block WNV
Replication but Repressed WNV-Induced Cell Death
It is possible that the resistance to WNV-induced cell death in
cells in which these seven genes were knocked out was due to
repression of WNV replication. Therefore, we tested viral replica-
tion in the surviving cells after WNV challenge. After 72 hr of WNV
challenge, whereas all of the cells in the control group had died
out, the cells treated with sgRNAs targeting the seven genes
Figure 3. Knockout of the Genes Identified Did Not Block WNV
Replication
(A) Cells derived as in Figure 2A were fixed and stained with WNV envelope
(ENV) protein antibody 72 hr after WNV (strain B956) challenge and analyzed
by flow cytometry. The mean fluorescence index (MFI) was used to represent
the WNV ENV protein level, and see also Figure S2. Vector-transfected cells
were included as a control, and the cells were fixed and analyzed at 24 hr post-
infection, which is the peak of WNV replication in WT 293FT cells. Error bar
represents 1 SD (n = 3).
(B) Cells were reseeded into a new 24-well plate. Supernatants were collected
72 hr later, and viral titers were determined by plaque assay. The control
reference level was the virus titer in the supernatant of WT cells infected with
WNV at 36 hr, which is the peak level of virus in the supernatant. Error bar
represents 1 SD (n = 3).had grown close to confluency (except EMC2 and EMC3). To
test viral replication, the cells were stained with WNV envelope
(ENV)-specific antibody and analyzed by flow cytometry. ENV
accumulation was seen in all the knockout cells, albeit at varying
levels. Interestingly, in all of these cells, the ENV level was higher
than the peak level in WT cells (Figures 3A and S2). To confirm
active viral replication, 3 days after infection, the cells were re-
seeded into a new plate and the WNV titers in the supernatant
determined at 72 hr by a plaque assay. The culture supernatant
from all knockout cells had a viral titer close to the peak level of
virus seen in WT cells at 36 hr (all infected WT cells died on day
3), suggesting that WNV production and release were not
blocked in these cells (Figure 3B). Thus, knockout of these genes
did not repress WNV replication but inhibited cell death induced
by WNV replication.
It is interesting that, although the cells were infected withWNV
and constantly produced WNV, most appeared to have normalmorphology and proliferated to the same extent as uninfected
cells, even after a period of months (data not shown). However,
EMC2- and EMC3-deficient cells were exceptional in this regard.
Although these cells grew to confluency, a portion of dead cells
was always observed (data not shown), probably because resis-
tance was not complete or because knockout of EMC2 or EMC3
negatively affected cell viability. Taken together, these results
suggest that knockout of these genes converts an acute infec-
tion into a chronic infection.
WNV Replication in EMC2 or SEL1L Knockout Sublines
To understand how knockout of these genes affects WNV-
induced cell death, we generated EMC2 and SEL1L knockout
sublines in 293FT cells (Figure S3A). It has been shown that, in
mammalian cells, SEL1L controls the stability of the E3 ligase
HRD1 and is essential both in vivo and in vitro for cell survival
(Sun et al., 2014). However, the SEL1L-deficient 293FT cells
grew as well as WT cells and appeared to have normal
morphology (data not shown). Thus, it appears that dependence
on SEL1L for survival is cell type specific. Consistent with the
sgRNA transfection data (Figure 2C), EMC2-deficient cells were
partially resistant to WNV-induced killing, whereas SEL1L-defi-
cient cells were fully resistant toWNV-induced killing (Figure 4A).
To exclude the possibility that off-target effects caused the resis-
tance, we performed a rescue experiment by transfecting the
EMC2 knockout 293FT subline with an EMC2 expression
plasmid. The killing of cells by WNV could indeed be restored
by expression of EMC2 (Figure 4B), suggesting that EMC2
knockout and not off-target knockout of unintended genes is
responsible for resistance to WNV-induced cell killing. We were
not able to perform the same experiment for SEL1L, because
transfection of SEL1L-expressing plasmid caused cell death.
Next, we determined the extent of viral replication in knockout
cells. The FACS analysis results appear to be consistent with our
earlier data in that knockout of either of these two genes did not
block viral ENV protein synthesis and virus release into the su-
pernatant, although it appears that viral replication was some-
what delayed (Figures 4C and 4D). Moreover, viral ENV protein
accumulated to similar or even higher levels in EMC2- or
SEL1L-deficient cells than in WT cells (Figure 4E). It is interesting
that the virus ENV protein level declined after reaching a peak at
24 hr in WT cells, whereas the ENV protein appeared to accumu-
late steadily in both knockout cells (Figure 4E). We also checked
the protein level of virus envelope, capsid, and nonstructural pro-
tein 3 (NS3) with western blotting. Consistent with the flow cy-
tometry data, the ENV level reached a peak at 24 hr and declined
at 36 hr inWT cells, whereas the protein continued to accumulate
over time to reach a level higher in knockout cells thanWT cells at
36 hr (Figure 4F). Interestingly, both the NS3 and capsid protein
levels were significantly lower in knockout cells. Thus, knocking
out EMC2 or SEL1L appears to have different effects on ENV
compared with capsid and NS3 proteins.
Resistance to the WNV-NY99 Strain and Saint Louis
Encephalitis Virus
The WNV-NY99 strain is pathogenic and most prevalent in the
USA. Thus, we tested resistance to this strain in cells in which
the seven genes had been knocked out individually. The resultsCell Reports 12, 673–683, July 28, 2015 ª2015 The Authors 677
Figure 4. WNV Replication in EMC2 or
SEL1L Knockout Sublines
(A) WNV resistance in EMC2- or SEL1L-deficient
sublines, which were generated as described in
Figure S4. The cells were challenged with WNV
(strain B956), and the cell viability was measured
with the MTT assay at different time points and
normalized to the respective controls withoutWNV
treatment. Error bar represents 1 SD (n = 3).
(B) Phenotypic rescue of EMC2 knockout cells.
The cells were transfected with EMC expression
plasmid and subjected to WNV challenge, and im-
ageswere taken72hr later. Thescalebar represents
400 mm. KO, knockout cells; WT, wild-type cells.
(C) Viral replication in EMC2- or SEL1L-deficient
cells. The cells were challenged with WNV and
fixed and stained with anti-WNV ENV antibody at
the indicated time points. The percentage of WNV
ENV-positive cells was determined by FACS, and
the raw data are found in Figure S4. Error bar
represents 1 SD (n = 3).
(D) The WNV released in the supernatant. The su-
pernatants were collected at the indicated time
points from WNV-challenged cells. The virion was
titrated by plaque assay and expressed as plaque-
forming units perml (pfu/ml). Error bar represents 1
SD (n = 3).
(E) The accumulation of WNV ENV protein inWNV-
infected cells at the indicated time points. The
protein level was represented by the MFI, and only
ENV-positive cellswere considered for calculation.
The raw data can be found in Figure S4. Error bar
represents 1 SD (n = 3).
(F) WNV ENV, nonstructural protein 3 (NS3), and
capsid protein levels in EMC- or SEL1L-deficient
cells at the indicated time points determined by
western blotting. Numbers below each lane indi-
cate the densitometry value in percentage relative
to actin.were consistent with those for the B956 strain, in which knockout
of thesesevengenesconferred resistance tocell death (Figure5A).
We also tested resistance of the knockout cells to Saint Louis
encephalitis virus (SLEV), which is a member of the flavivirus
family and is closely related to WNV. As shown in Figure 5B,
the knockout cells showed resistance to SLEV-induced cell
death, although to a lesser extent than WNV (Figure 5B).
Validating the Identified Genes in Other Cell Lines
To exclude the possibility that the identified genes work only in
293FT cells, we tested the effect of knocking out the genes in
HeLa cells and also in a more-relevant neuronal cell line, Neuro-
2a. The cellswere transfectedwith sgRNAsandCas9-expressing
plasmids and selected with puromycin, and the knockout effi-
ciency was confirmed by western blotting (Figures S3B and
S3C). The cells were challenged withWNV B956 or NY99 strains.
ForNeuro-2a cells, knockout of thesegenesconferred resistance678 Cell Reports 12, 673–683, July 28, 2015 ª2015 The Authorsto both strains compared to vector control
(Figures 5C and 5D). For HeLa cells,
knockout of the seven genes also
conferred resistance to B956 strain-induced cell death; however, knockout of EMC2 and EMC3
conferred stronger resistance than the other five genes (Fig-
ure 5E). For the NY99 strain, only knockout of EMC2 and EMC3
conferred close to 100% resistance to WNV-induced cell death,
whereas knockout of the other five genes conferred minimal or
no resistance to WNV-induced cell death compared to vector
control (Figure 5F). It is interesting that knockout of CBLL1
conferred minimal but significant resistance to WNV-induced
cell death in HeLa cells, in which CBLL1was previously identified
in a genome-wide siRNA library screening (Krishnan et al., 2008).
Thus, CBLL1 can serve as a positive control in HeLa cells.
DISCUSSION
Using an independently designed CRISPR-Cas9-based
screening method, we identified seven genes that are essential
for WNV-induced cell death.
Figure 5. Validating the Identified Genes with Different WNV Strains, SLEV, as well as Neuro-2a and HeLa Cells
The 293FT knockout cells prepared as in Figure 2 were infected withWNV-NY99 (A) or SLEV (B) at moi = 2. The resistance was determined as in Figure 2C. Neuro-
2a and HeLa cells were treated as in Figure 2A to generate knockout cells. The knockout efficiency was determined by western blotting, as shown in Figure S4.
The knockout cells were infected with the WNV B956 strain (C, Neuro-2a; E, HeLa) or the NY99 strain (D, Neuro-2a; F, HeLa), and the resistance was determined
as in Figure 2C. Error bar represents 1 SD (n = 3).
Cell Reports 12, 673–683, July 28, 2015 ª2015 The Authors 679
Figure 6. The Proteins Encoded by the
Seven Genes Belonging to the ERAD
Pathway Might Be the Missing Connection
between WNV Replication and the Ensuing
Cell Death
(A) The essential WNV-induced cell death factors
identified belong to two protein complexes that
interact through DERL2. Solid black circles, the
identified host factors. Open circles, other com-
ponents of the two complexes.
(B) ERAD might be the missing connection be-
tween WNV replication and ensuing cell death.Unlike previously reported CRISPR-Cas9-based screening, in
which Cas9 was stably expressed (Koike-Yusa et al., 2014; San-
jana et al., 2014; Shalem et al., 2014; Wang et al., 2014; Zhou
et al., 2014), we expressed Cas9 transiently. The reason for using
transient expression of Cas9 was that it might reduce any off-
target effects that might be amplified by stable expression of
Cas9. However, it has been shown that prolonged expression
of Cas9 and sgRNA can significantly increase the knockout effi-
ciency (Shalem et al., 2014). Thus, transient expression of Cas9
might have decreased the sensitivity of our system.
Although in the first round of screening wewere able to identify
several genes, such as SEL1L, EMC2, and EMC3, that are
essential for WNV-induced cell death (Table S1; Data Set S2),
it is clear that some other genes probably remained unidentified
due to the high noise level.Whereas such an unusually high noise
level was observed in both rounds of screening for WNV host
factors (Data Sets S2 and S4), this was not observed in our pre-
vious screening for HIV host factors (data not shown). Therefore,
the high level of noise might not be a problem with our screening
strategy per se. A possible explanation for the high noise level
observed in WNV host factor screening is that traces of genomic
DNA were somehow left behind by the cells killed by WNV repli-
cation. Because millions of cells were used before virus chal-
lenge, contamination with even 0.1% of the genomic DNA (inte-
grated with different sgRNAs) would be enough to cause a high
noise level. However, by using a sub-library targeting the genes
enriched in the first round of screening, we were able to effec-
tively distinguish true hits from noise, and all of the top candi-
dates were validated as essential WNV-induced cell death680 Cell Reports 12, 673–683, July 28, 2015 ª2015 The Authorsgenes. In a sense, the second-round
screening itself served as a large-scale
validation of the genes enriched in the
first round. Thus, our approach provides
a general strategy to increase the speci-
ficity and sensitivity of CRISPR-mediated
screening, even in the setting of a high
noise level.
Defining a good criterion for choosing
the sgRNAs and genes from the
screening data is critical to improving
the data quality. Based on our data, it ap-
pears that a sgRNA with a high number of
reads across independent experiments is
a reliable indication that the targetedgene is essential for WNV-induced cell death. For example,
only one sgRNA was identified for the HRD1 gene in the first
round of screening; however, this sgRNA had a high number of
reads in all three independent experiments. And indeed, HRD1
was validated with two individual sgRNAs to be a truly essential
gene for WNV-induced cell death. Thus, reproducibility across
biological replicates appears to be a reliable criterion for
choosing sgRNAs.
Among the genes identified, seven genes stood out as having
the strongest phenotype, whose knockout conferred strong pro-
tection against WNV-induced cell death (Figure 2). Interestingly,
all of these genes belong to the ERAD pathway and aremembers
of two complexes that interact with each other. Whereas SEL1L,
HRD1, UBE2J1, DERL2, and UBE2G2 belong to the SEL1L–
HRD1 complex, EMC2 and EMC3 belong to the mammalian
ER membrane complex (mEMC), a newly discovered complex
that is poorly understood (Christianson et al., 2012). These two
complexes appear to interact with each other through DERL2
(Christianson et al., 2012) (Figure 6A). It is unlikely to be a coinci-
dence that all of the top genes identified belong to the same
complex. Rather, it suggests that our screening strategy with
two rounds of screening can identify most, if not all, of the genes
involved in a biological process.
ERAD is a mechanism for degrading misfolded or misas-
sembled proteins in the ER (Christianson and Ye, 2014). Flavi-
viruses, including WNV, are known to replicate in close associ-
ation with ER-derived membrane structures and to induce ER
stress (Brinton, 2014), and some components of the ERAD
pathway have been shown to play a role in flavivirus replication
(Krishnan et al., 2008; Li et al., 2014; Saeed et al., 2011;
Sharma et al., 2014) as well as the replication of other viruses
(Bennett et al., 2013; Bernasconi et al., 2012; Reggiori et al.,
2010; van den Boomen et al., 2014). It is known that WNV repli-
cation induces cell death; however, how exactly WNV replica-
tion triggers this is unknown. Until now, involvement of the
ERAD pathway has been unsuspected. Our study showed
that seven genes of the ERAD pathway are essential for activa-
tion of the downstream cell death pathway. Knockout of these
genes did not prevent WNV replication or release but did block
WNV replication-induced cell death (Figures 2, 3, and 4). Thus,
our results suggest that ERAD might be the primary driver of
WNV replication-induced cell death and might be the missing
connection between WNV replication and ensuing cell death
(Figure 6B).
The ER membrane protein complex (EMC) was first identi-
fied in yeast, and it appears that loss of EMC leads to accu-
mulation of misfolded proteins, suggesting that they might
also be components of ERAD (Jonikas et al., 2009). More
recently, Christianson et al. (2012) showed that EMC was
also present in mammalian cells and interacted with other
ERAD components through DERL2 and UBAC2. However,
the exact function of the EMC is poorly understood. Our study
revealed that two components of the EMC, EMC2 and EMC3,
play important roles during WNV-induced cell death. Knockout
of these genes confers strong resistance to different WNV
strains and SLEV in different cell lines (Figures 2C and 5).
Moreover, it appears that the effect of knocking out EMC2
and EMC3 is different with the other five genes. The effect
of EMC2 and EMC3 knockout was weaker in 293FT cells (Fig-
ures 2C and 5A) but stronger in HeLa cells (Figures 5E and
5F), suggesting that the mechanism by which these two
groups of genes regulate WNV-induced cell death might be
different. It will be interesting to elucidate the exact role of
the EMC in WNV-induced cell death.
A previous genome-wide screen using a siRNA library identi-
fied 283 host susceptibility factors (HSFs) whose silencing
reducedWNV replication. Among these 283 genes, ten are com-
ponents of the ERAD pathway. Three of the ten, HRD1, DERL2,
and UBE2J1, were also identified in our screening as essential
genes whose knockout blocks WNV-induced cell death. It is
noteworthy that the previous RNAi study screened for genes
whose knockdown caused diminished WNV replication at
24 hr, whereas we screened for genes whose knockout blocked
WNV-induced cell death.
The effect of knocking out the genes we identified was vali-
dated with different WNV strains in different cell lines (Figures
2C, 5A, and 5C–5F). In addition toWNV, knockout of these genes
also conferred resistance to SLEV (Figure 5B). Thus, the seven
genes that we have identified might have a broader role in
virus-induced cell death.
In conclusion, seven ERAD family members appear to be
essential for WNV infection to cause cell death and in the
absence of them, although viral replication continues, cells sur-
vive. Because massive neuronal cell death is one of the major
causes for mortality in WNV infection, ERAD proteins we identi-
fied might provide novel therapeutic targets to prevent WNV-
induced mortality.EXPERIMENTAL PROCEDURES
Cells and Viruses
293FT and HeLa cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) (Life Technologies) with high glucose. The medium was supple-
mented with 10% fetal bovine serum (FBS) (Life Technologies) and peni-
cillin-streptomycin (Life Technologies). All cells were maintained at 37C and
5% CO2 in a humidified incubator. The WNV-B956 strain was grown and
titrated as previously described (Kumar et al., 2006). The WNV-NY99 strain
and SLEV were obtained from ATCC and grown in C6/36 cells. The titers
were determined by plaque assay in BHK-21cells.
sgRNA Library Construction
The sequences of human protein-coding transcripts were downloaded from
Ensembl (Biomart 70). The sgRNA target sites were selected based on the
following rules: they must start with a G or A (both nucleotides can initiate tran-
scription from the U6 promoter; data not shown) and have a PAM motif 20 nt
downstream. Two target sites per exon were chosen from the first two exons
immediately after the start codon. If not enough target sites were found in
these two exons, sites were chosen from the following exons until there
were four target sites for each transcript. To all target site oligos, the sequence
TCTACAGTCCGACGATCATGCAT was added to the 50 end and the sequence
GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTT
GAAAAAGTGGCACCGAGTCGGTGCTTT was added to the 30 end. The library
was synthesized as an oligo pool (CustomArray), which was purified on a 15%
urea gel and PCR amplified with the primers TCTACAGTCCGACGATCATG
CAT (forward) and ATCGAACGTTGTCAGCATCTCGAGAAAAAAGCACCGAC
TCGGTG (reverse). The amplified oligos were digested with NsiI followed by
Pfx50 (Life Technologies) treatment for 10 min at 68C to generate blunt
ends and then digested with XhoI. The oligos were then ligated with the pLB
vector digested with HpaI and XhoI. The ligated plasmids were transformed
into E. coli and cultured overnight. By sampling 0.1% of the transformations
in the plates, we estimated that there were 1.52 3 106 colonies in total, which
should cover the library 20 times.
Lentiviral Library Packaging
The library was packaged with the ViraPower lentivirus expression system.
293FT cells were seeded in 150-cm2 culture dishes at 1 3 107 cells per dish.
After overnight culture, the medium was replaced with DMEM medium con-
taining 2.5% FBS. A mixture containing 10 mg of library plasmid and 30 mg of
ViraPower packaging plasmid mix was transfected using the classic HEPES-
calcium phosphate transfection method. Six hours later, the supernatants
were changed back to culture medium. Forty-eight hours after transfection,
culture supernatants were collected, clarified by centrifugation, filtered with
0.45-mm filters, and aliquoted for 80C storage until use.
Lentiviral Transduction
293FT cells (43 107) were transduced at moi = 0.05. The transduction rate was
5%, as analyzed by FACS at 72 hr after transduction. The cells were then
sorted on a FACSAria II cell sorter, and it was confirmed that >90% of the
sorted cells were GFP positive. The sorted cells were kept in culture under
the same conditions as the original 293FT cells. Approximately 5 3 106 cells
were recovered, which was expanded to 2 3 107 cells in the next step.
Screening for Genes Essential for WNV-Mediated Killing
Cells (2 3 107) harboring the sgRNA library were transfected with the pX261–
dU6 plasmid using Lipofectamine 2000 (Life Technologies), according to the
manufacturer’s instructions. The transfected cells were infected with the
WNV-B956 strain at moi = 2 and incubated for 12 days.
sgRNA Recovery
Genomic DNA was extracted from the surviving cells, and sgRNA sequences
were amplified by nested PCR with the first pair of primers, GATAGGCTTG
GATTTCTATAAG (forward) and CTGCTGGAATCTCGTGAAG (reverse), fol-
lowed by amplification with the second pair of primers, AATGATACGGCGAC
CACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNC
TTGGAGAAAAGCCTTGTT (forward) and CAAGCAGAAGACGGCATACGACell Reports 12, 673–683, July 28, 2015 ª2015 The Authors 681
GATXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCGCTATTTCT
AGCTCTAAAAC (reverse, where XXXXXX indicates index sequences) to add
an index sequence and sequences required for Illumina second-generation
sequencing technology. After sequencing with MiSeq, the sgRNA sequences
were recovered by decoding with the index sequence and removing the 50
and 30 sequences to identify the genes that are essential for virus-induced
cell killing.
Validation of the Genes Identified
sgRNAs were designed as oligos and inserted into the pX330-U6-Chimer-
ic_BB-CBh-hSpCas9 vector (Addgene plasmid 42230) at the BbsI site (Cong
et al., 2013). The oligo sequences are listed in Table S4. The constructs
were co-transfected using Lipofectamine 2000 into 293FT or HeLa cells with
a puromycin-expressing plasmid, pX261–dU6, which was modified from
the pX261-U6-DR-hEmx1-DR-Cbh-NLS-hSpCas9-NLS-H1-shorttracr-PGK-
puro plasmid (Addgene plasmid 42337) by deleting the fragment harboring
the U6 promoter and crRNA. Puromycin was added 1 day after transfection
at 3 mg/ml for 293FT cells, HeLa cells, or Neuro-2a cells and incubated for
2 days. After removing puromycin, the cells were allowed to recover for
3–6 days before WNV challenge. The knockout efficiency was determined by
amplifying the target sites with the primers in Table S5, followed by deep
sequencing of 293FT cells and western blotting for all three cells. The recov-
ered cells were challenged with WNV at moi = 2. After incubating for 3 days
for 293FT or Neuro-2a cells and 2 days for HeLa cells, the cell viability was eval-
uated with the MTT assay as per the manufacturer’s instructions (Promega).
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